RoseEA, MoskowitzAJ, PackerM, et al.: The REMATCH trial: Rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg, 1999; 67:723–730.
2.
StarlingRC, NakaY, BoyleAJ, et al.: Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: A prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol, 2011; 57:1890–1898.
3.
AdamsEE, WrightsonML: Quality of life with an LVAD: A misunderstood concept. Heart Lung, 2018; 47:177–183.
4.
ChuziS, HaleS, ArnoldJ, et al.: Pre-ventricular assist device palliative care consultation: A qualitative analysis. J Pain Symptom Manage, 2019; 57:100–107.
5.
KirklinJK, PaganiFD, KormosRL, et al.: Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant, 2017; 36:1080–1086.
6.
JacquesL, JensenTS, SchaferJ, et al.: Decision Memo for Ventricular Assist Devices for Bridge-to-Transplant and Destination Therapy. Baltimore, MD: Centers Medicare Medicaid Services, 2013, pp. 1–91.
7.
WoodburnJL, StaleyLL, WordinghamSE, et al.: Destination therapy: Standardizing the role of palliative medicine and delineating the DT-LVAD Journey. J Pain Symptom Manage, 2019; 57330–340.e334.
8.
SwetzKM, KamalAH, MatlockDD, et al.: Preparedness planning before mechanical circulatory support: A “how-to” guide for palliative medicine clinicians. J Pain Symptom Manage, 2014; 47:926–935.e926.
9.
O'ConnorNR, MoyerME, KirkpatrickJN: Scripted nurse visits: A resource-efficient palliative care model for ventricular assist devices. J Palliat Med, 2016; 19:1312–1315.
10.
GoldsteinNE, MayCW, MeierDE: Comprehensive care for mechanical circulatory support: A new frontier for synergy with palliative care. Circ Heart Fail, 2011; 4:519–527.
11.
AllenLA, McIlvennanCK, ThompsonJS, et al.: Effectiveness of an intervention supporting shared decision making for destination therapy left ventricular assist device: The DECIDE-LVAD Randomized Clinical Trial. JAMA Intern Med, 2018; 178:520–529.
12.
BernackiRE, BlockSD: Communication about serious illness care goals: A review and synthesis of best practices. JAMA Intern Med, 2014; 174:1994–2003.
13.
Ben GalT, JaarsmaT. Self-care and communication issues at the end of life of recipients of a left-ventricular assist device as destination therapy. Curr Opin Support Palliat Care, 2013; 7:29–35.
14.
NakagawaS, YuzefpolskayaM, ColomboPC, et al.: Palliative care interventions before left ventricular assist device implantation in both bridge to transplant and destination therapy. J Palliat Med, 2017; 20:977–983.
15.
DeFilippisEM, NakagawaS, MaurerMS, TopkaraVK: Left ventricular assist device therapy in older adults: addressing common clinical questions. J Am Geriatr Soc, 2019; 67:2410–2419.
